Lisa Walter
Stock Analyst at RBC Capital
(3.06)
# 2,646
Out of 4,974 analysts
89
Total ratings
53.9%
Success rate
3.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lisa Walter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RYTM Rhythm Pharmaceuticals | Reiterated: Buy | $155 | $96.77 | +60.17% | 8 | Sep 14, 2026 | |
| UTHR United Therapeutics | Reiterated: Buy | $677 | $500.35 | +35.31% | 13 | Aug 25, 2026 | |
| EYPT EyePoint | Downgraded: Hold | $37 → $5 | $3.66 | +36.61% | 10 | Aug 17, 2026 | |
| FDMT 4D Molecular Therapeutics | Reiterated: Buy | $35 | $13.63 | +156.79% | 25 | Aug 14, 2026 | |
| KRYS Krystal Biotech | Initiated Coverage: Buy | $400 | $336.68 | +18.81% | 1 | Aug 14, 2026 | |
| MGTX MeiraGTx Holdings | Reiterated: Buy | $26 → $27 | $12.76 | +111.60% | 9 | Aug 13, 2026 | |
| IRD Opus Genetics | Reiterated: Buy | $10 → $9 | $5.82 | +54.64% | 2 | Aug 6, 2026 | |
| MIRM Mirum Pharmaceuticals | Reiterated: Buy | $148 → $135 | $93.90 | +43.77% | 3 | Aug 6, 2026 | |
| VRDN Viridian Therapeutics | Reiterated: Buy | $35 → $36 | $21.83 | +64.91% | 7 | Aug 6, 2026 | |
| OCUL Ocular Therapeutix | Reiterated: Buy | $30 | $10.19 | +194.41% | 11 | Aug 3, 2026 |
Rhythm Pharmaceuticals
Sep 14, 2026
Reiterated: Buy
Price Target: $155
Current: $96.77
Upside: +60.17%
United Therapeutics
Aug 25, 2026
Reiterated: Buy
Price Target: $677
Current: $500.35
Upside: +35.31%
EyePoint
Aug 17, 2026
Downgraded: Hold
Price Target: $37 → $5
Current: $3.66
Upside: +36.61%
4D Molecular Therapeutics
Aug 14, 2026
Reiterated: Buy
Price Target: $35
Current: $13.63
Upside: +156.79%
Krystal Biotech
Aug 14, 2026
Initiated Coverage: Buy
Price Target: $400
Current: $336.68
Upside: +18.81%
MeiraGTx Holdings
Aug 13, 2026
Reiterated: Buy
Price Target: $26 → $27
Current: $12.76
Upside: +111.60%
Opus Genetics
Aug 6, 2026
Reiterated: Buy
Price Target: $10 → $9
Current: $5.82
Upside: +54.64%
Mirum Pharmaceuticals
Aug 6, 2026
Reiterated: Buy
Price Target: $148 → $135
Current: $93.90
Upside: +43.77%
Viridian Therapeutics
Aug 6, 2026
Reiterated: Buy
Price Target: $35 → $36
Current: $21.83
Upside: +64.91%
Ocular Therapeutix
Aug 3, 2026
Reiterated: Buy
Price Target: $30
Current: $10.19
Upside: +194.41%